H Greinix

Author PubWeight™ 31.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic fingerprinting in mouthwashes of patients after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999 2.53
2 An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant 2003 2.19
3 Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 2011 1.85
4 Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation 2000 1.55
5 Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology. Ann Oncol 1997 1.43
6 Central venous catheter pinch-off and fracture: recognition, prevention and management. Bone Marrow Transplant 2003 1.41
7 Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998 1.30
8 Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia 2011 1.24
9 Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood 1997 1.20
10 Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant 2012 1.17
11 Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. Bone Marrow Transplant 2010 1.16
12 Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health. Bone Marrow Transplant 2008 1.14
13 Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood 1995 1.07
14 The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation. Int J Immunogenet 2008 0.94
15 AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 1994 0.93
16 WT1-specific serum antibodies in patients with leukemia. Clin Cancer Res 2001 0.89
17 Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation. Bone Marrow Transplant 2013 0.86
18 Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 2014 0.85
19 Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy. Eur Heart J 1991 0.84
20 Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption. Bone Marrow Transplant 2003 0.84
21 [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654]. Padiatr Padol 1986 0.84
22 Specificities of anti-platelet antibodies in multitransfused patients with haemato-oncological disorders. Br J Haematol 1996 0.83
23 Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease. J Eur Acad Dermatol Venereol 2014 0.83
24 Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia. Leukemia 1998 0.82
25 Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma. Ann Hematol 2001 0.81
26 Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand. Blood 1994 0.80
27 Histopathological diagnosis of graft-versus-host disease of the skin: an interobserver comparison. J Eur Acad Dermatol Venereol 2013 0.79
28 Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD. Bone Marrow Transplant 2008 0.78
29 Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction. Br J Haematol 2000 0.77
30 T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation. Int J Lab Hematol 2008 0.77
31 [Advances in the treatment of chronic lymphocytic leukemia (CLL)]. Wien Klin Wochenschr 1998 0.75
32 Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic features. Ann Oncol 2003 0.75
33 Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP). Bone Marrow Transplant 1997 0.75
34 Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26). Ann Hematol 2000 0.75
35 Suppression of chronic lymphocytic leukaemia by megakaryocytic myelosis. Haematologia (Budap) 1994 0.75
36 Autoantibody-mediated agranulocytosis in association with chronic GVHD. Bone Marrow Transplant 2008 0.75
37 Treatment of acute leukemia. Ann Oncol 1999 0.75
38 PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia. Br J Haematol 1995 0.75
39 Cyclosporin A-induced ocular flutter after marrow transplantation. Bone Marrow Transplant 1997 0.75
40 Positive selection of CD34+ cells by immune affinity. Beitr Infusionsther Transfusionsmed 1997 0.75
41 [Place of high-dose therapy in breast cancer. Austrotransplant consensus conference 1999]. Wien Klin Wochenschr 2000 0.75